Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 1/20 | 0.62 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | FASN | P49327 | 1/20 | 0.44 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.41 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 2/20 | 0.41 |
| ▸ | CNR1 | P21554 | 2/20 | 0.41 |
| ▸ | CNR2 | P34972 | 2/20 | 0.41 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28862954 | 1.00 | PPARA (0.62) | PPARAPTPN1ACHEBACE1KDM4E | |
| SCHEMBL3129770 | 1.00 | PPARA (0.62) | PPARAPTPN1ACHEBACE1KDM4E | |
| SCHEMBL3128974 | 1.00 | PPARA (0.62) | PPARAPTPN1ACHEBACE1KDM4E | |
| SCHEMBL17540807 | 1.00 | PPARA (0.62) | PPARAPTPN1ACHEBACE1KDM4E | |
| SCHEMBL8345723 | 1.00 | PPARA (0.62) | PPARAPTPN1ACHEBACE1KDM4E | |
| SCHEMBL6598890 | 1.00 | PPARA (0.62) | PPARAPTPN1ACHEBACE1KDM4E | |
| SCHEMBL3128979 | 1.00 | PPARA (0.62) | PPARAPTPN1ACHEBACE1KDM4E | |
| SCHEMBL13725844 | 1.00 | PPARA (0.62) | PPARAPTPN1ACHEBACE1KDM4E | |
| SCHEMBL21518030 | 1.00 | PPARA (0.62) | PPARAPTPN1ACHEBACE1KDM4E | |
| SCHEMBL29533700 | 1.00 | PPARA (0.62) | PPARAPTPN1ACHEBACE1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022198813-A1 | USE OF 15(S)-HYDROXYEICOSATETRAENOIC ACID IN EVALUATION OF EFFECT OF ALLERGEN SPECIFIC IMMUNOTHERAPY | 广州医科大学附属第一医院（广州呼吸中心） | 2022-09-29 | — | — | WO | claimed |
| WO-1999021425-A1 | TRIGEMINAL SENSORY STIMULI AND ANIMAL REPELLENTS FROM PLANTS | MONELL CHEMICAL SENSES CENTER (US) | 1999-05-06 | — | — | WO | claimed |
| US-4711902-A | FATTY ACID ESTER | BAYER AKTIENGESELLSCHAFT (DE) | 1987-12-08 | — | — | US | claimed |
| CN-119405579-A | Whitening composition with after-sun restoration effect, application thereof, cosmetic and preparation method thereof | 麦吉丽生物科技有限公司 | 2025-02-11 | — | — | CN | disclosed |
| US-20240218254-A1 | ADDITIVE FOR SURFACE ACTIVATION, AND EMULSION COMPOSITION USING SAME | MIYOSHI OIL & FAT CO., LTD. (JP) | 2024-07-04 | — | — | US | disclosed |
| CN-117203308-A | Additive for making interface active and emulsifying composition using the same | 三吉油脂株式会社 | 2023-12-08 | — | — | CN | disclosed |
| WO-2022225049-A1 | ANTIBACTERIAL AGENT, ANTIBACTERIAL COMPOSITION USING SAME AND ANTIVIRAL COMPOSITION | ミヨシ油脂株式会社 | 2022-10-27 | — | — | WO | disclosed |
| WO-2022225047-A1 | ADDITIVE FOR ACTIVATING INTERFACE, AND EMULSION COMPOSITION USING SAME | ミヨシ油脂株式会社 | 2022-10-27 | — | — | WO | disclosed |
| WO-2022198813-A1 | USE OF 15(S)-HYDROXYEICOSATETRAENOIC ACID IN EVALUATION OF EFFECT OF ALLERGEN SPECIFIC IMMUNOTHERAPY | 广州医科大学附属第一医院（广州呼吸中心） | 2022-09-29 | — | — | WO | disclosed |
| CN-114867476-A | Enriched polyunsaturated fatty acid compositions | 纽希得营养(美国)公司 | 2022-08-05 | — | — | CN | disclosed |
| EP-3185873-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | Lipocine Inc. (US) | 2017-07-05 | — | — | EP | disclosed |
| CN-106617106-A | Nutritional supplement capable of delaying senescence | 常宸 | 2017-05-10 | — | — | CN | disclosed |
| WO-2016033536-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2016-03-03 | — | — | WO | disclosed |
| WO-2016033611-A1 | (17-β)-3-OXOANDROST-4-EN-17-YL UNDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE | LIPOCINE INC. (US) | 2016-03-03 | — | — | WO | disclosed |
| US-7731992-B2 | astaxanthin, black cohosh, echinacea, and phytosterols, antitumor agents for breast cancer | TRIARCO INDUSTRIES, INC. (US) | 2010-06-08 | — | — | US | disclosed |
| US-20100009927-A1 | Anti-Inflammatory and Anti-Allergy Extracts from Nettle | HERBALSCIENCE GROUP LLC (US) | 2010-01-14 | — | — | US | disclosed |
| US-20040156926-A1 | Method of inhibiting aromatase with specific dietary supplements | TRIARCO INDUSTRIES, INC. | 2004-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240218254-A1 | ADDITIVE FOR SURFACE ACTIVATION, AND EMULSION COMPOSITION USING SAME | HAO2, NOTUM, FFAR2 | PPARA 61/4885PTPN1 2888/4885ACHE 1651/4885 |
| US-20040156926-A1 | Method of inhibiting aromatase with specific dietary supplements | CYP19A1, HSD17B11, SHBG | PPARA 1619/4885PTPN1 4477/4885ACHE 42/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.